Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome

Efficacy of anidulafungin, caspofungin and fluconazole in the early phase of infection in a neutropenic murine invasive candidiasis model

(2010) Suganthini Krishnan-Natesan et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry

(2009) David L. Horn et al.   CLINICAL INFECTIOUS DISEASES

Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America

(2009) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Candida albicans RFX2Encodes a DNA Binding Protein Involved in DNA Damage Responses, Morphogenesis, and Virulence

(2009) Binghua Hao et al.   EUKARYOTIC CELL

Activity of Contemporary Antifungal Agents, Including the Novel Echinocandin Anidulafungin, Tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: Report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007)

(2009) S. A. Messer et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Rationale for Reading Fluconazole MICs at 24 Hours Rather than 48 Hours When Testing Candida spp. by the CLSI M27-A2 Standard Method

(2008) L. Ostrosky-Zeichner et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effect of inducible nitric oxide synthase on apoptosis in Candida-induced acute lung injury

(2008) Shigekuni Hosogi et al.   BIOMEDICAL RESEARCH-TOKYO